News
LFCR
6.00
-1.48%
-0.09
Weekly Report: what happened at LFCR last week (0210-0214)?
Weekly Report · 1d ago
Weekly Report: what happened at LFCR last week (0203-0207)?
Weekly Report · 02/10 09:17
Arquitos Capital Management Q4 2024 Commentary
Seeking Alpha · 02/05 12:10
Weekly Report: what happened at LFCR last week (0127-0131)?
Weekly Report · 02/03 09:17
Summers Value Partners Q4 2024 Partner Letter
Seeking Alpha · 01/30 13:30
Weekly Report: what happened at LFCR last week (0120-0124)?
Weekly Report · 01/27 09:18
Weekly Report: what happened at LFCR last week (0113-0117)?
Weekly Report · 01/20 09:17
Lifecore Biomedical Announces Special Stockholder Meeting
Barchart · 01/17 16:24
Laughing Water Capital Q4 2024 Letter
Seeking Alpha · 01/16 12:50
Weekly Report: what happened at LFCR last week (0106-0110)?
Weekly Report · 01/13 09:17
Friday 1/10 Insider Buying Report: FDX, LFCR
NASDAQ · 01/10 15:35
Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical
Simply Wall St · 01/10 11:04
Lifecore CEO buys $97.6K in common stock
TipRanks · 01/08 22:05
Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)
TipRanks · 01/08 14:17
Lifecore Biomedical’s Strategic Asset Sale Supports Hold Rating Amid Leverage Concerns
TipRanks · 01/08 14:15
Lifecore Biomedical to sell multi-purpose 10-head isolator filler
Seeking Alpha · 01/07 15:36
Lifecore entered into sales agreement for 10-head isolator filler
TipRanks · 01/07 14:15
Lifecore Biomedical Announces $17M Sales Agreement For 10-Head Isolator Filler, Receives $7M At Closing, Expects Remaining Payments In 3 Tranches Over 18 Months
Benzinga · 01/07 14:08
*Lifecore Biomedical Sells Excess Capital Equipment for $17M
Dow Jones · 01/07 14:01
LIFECORE BIOMEDICAL FURTHER STRENGTHENS FINANCIAL POSITION THROUGH SALE OF EXCESS CAPITAL EQUIPMENT FOR $17 MILLION
Reuters · 01/07 14:00
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.